12-Month Lobbying Summary - In-house Corporation

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	COVID-19: Regarding the development of policies and programs to address the COVID-19 pandemic and support the re-opening of the Canadian economy, including as it relates to tackling health equity across marginalized communities in Canada and surgical backlogs.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Canada’s engagement and leadership on programs and policies relating to mental health both domestic and international	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Canada’s partnerships on global health and global community impact with Johnson & Johnson relating to maternal and child health, First Nations, mental health and other areas	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Changes to NAFTA to address United States-Mexico-Canada Agreement (USMCA) relevant for life sciences sector	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	Chemical Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in therapeutic products	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communiation to officials regarding the Regulatory Cooperation council.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communication regarding the review by the Health Committee on regulation of e-cigarettes.	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communication to officials on labelling and product monographs.	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communication to officials regarding Look Alike Sound Alike Guidance communication.	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to any aspects which affect the local business environment for J&J Inc.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of consumer products.	Policies or Program, Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding maintenance of domestic supply of essential consumer products, including in relation to the Drug Shortages Task Force.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding maintenance of domestic supply of essential consumer products.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding regulations relating to labelling and product monographs.	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding the Chemicals Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in consumer health products.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding the development of federally funded programs or other policies to reach the Canadian government’s stated goal of 5% tobacco usage by 2035.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding the retail manufacturing code of conduct for food and health products and the grocery code of conduct.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Communications regarding the retail manufacturing code of conduct for food and health products.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Engagement on government’s Innovation Agenda as it relates to Health and Bio Sciences sector	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Engaging government on issues relating to the potential implementation of National Pharmacare	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Evolution of role and mandate of drug pricing regime in Canada	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Food and Drug Act: Delays in product approvals and changes to existing products	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Food and Drug Regulation: Nonprescription drugs labelling standards - Drug Products: Draft Guidance Document: Nonprescription Oral Pediatric Cough and Cold Labelling Standard,participated in Health Canada's consultation process	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of therapeutic products	Policies or Program, Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Local manufacturing of healthcare products – Regarding the development of policies and programs (including funding programs) to support the expansion of existing manufacturing facilities or the establishment of additional manufacturing capacity in Canada.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Modernizations of the Food and Drugs Act, with respect to inspection, reporting and confidential business information	Regulation
  Subject matters were not required to be associated with subject matter details when this content was submitted	Self-care – Regarding the development of policies and programs to support self-care, and safe use of consumer health products.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Self-care – Regarding the development of policies and programs to support self-care, including tax incentives for self-care products that have an impact on health (for e.g. sunscreen, smoking cessation).	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Smoking cessation – Regarding the development of federally funded programs or other policies to facilitate smoking cessation (for e.g. tobacco tax).	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Treasury Board initiative to address international regulatory cooperation as well as their work on the Canada US, and Canada EU Regulatory Cooperation Councils	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Zero plastic waste by 2030 – Regarding legislative proposals regulating plastic packaging and implementing plastic waste management programs.	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	Zero plastic waste by 2030 – Regarding potential legislative proposal regulating harmful single-use plastic items and implementing plastic waste management programs.	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	any regulatory changes that may emerge relating to the policy areas identified above including Health Canada Modernization efforts, Patented Medicine Prices Review Board (PMPRB), Treasury Board Initiative on international regulatory cooperation	Regulation

  Subject matters in previous versions

  • Budget
  • Consumer Issues
  • Economic Development
  • Environment
  • Health
  • Industry
  • Intellectual Property
  • International Trade
  • Taxation and Finance

Government Institutions

• Agriculture and Agri-Food Canada (AAFC)
• Environment and Climate Change Canada (ECCC)
• Federal Economic Development Agency for Southern Ontario (FedDev)
• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Indigenous Services Canada (ISC)
• Innovation, Science and Economic Development Canada (ISED)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Senate of Canada
• Treasury Board Of Canada Secretariat (TBS)

• Government institutions in previous versions

  • Canada Economic Development for Quebec Regions
  • Canada Revenue Agency (CRA)
  • Canadian Heritage (PCH)
  • Canadian Radio-television and Telecommunications Commission (CRTC)
  • Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
  • Employment and Social Development Canada (ESDC)
  • Justice Canada (JC)
  • Pacific Economic Development Canada (PacifiCan)
  • Patented Medicine Prices Review Board (PMPRB)
  • Transport Canada (TC)
  • Transportation Safety Board of Canada (TSB)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Oral communication
• Written communication

Senior Officers whose lobbying activities represent less than 20% of their Duties

• Katie Decker, Managing Director, Canada | No public offices held
• Katherine Lal, Leader, Communications & Government Affairs | No public offices held
• Hillary Orr, Director, Regulatory Affairs | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

• Lobbyists in previous versions

  Senior Officers whose lobbying activities represent less than 20% of their Duties

  • Cory Price, Managing Director | No public offices held